These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 23127735)

  • 21. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey CF; Eckmann L; Fuhrmann V
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.
    Di X; Bai N; Zhang X; Liu B; Ni W; Wang J; Wang K; Liang B; Liu Y; Wang R
    Braz J Infect Dis; 2015; 19(4):339-49. PubMed ID: 26001980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
    Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
    Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Clostridium difficile infections.
    Soriano MM; Johnson S
    Infect Dis Clin North Am; 2015 Mar; 29(1):93-108. PubMed ID: 25573676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
    Mizusawa M; Doron S; Gorbach S
    Drugs Aging; 2015 Aug; 32(8):639-47. PubMed ID: 26233437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence.
    Zar FA
    Ann Intern Med; 2016 Jul; 165(2):JC4. PubMed ID: 27429316
    [No Abstract]   [Full Text] [Related]  

  • 27. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
    Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
    Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clostridium difficile infection: epidemiology, disease burden and therapy].
    Gulácsi L; Kertész A; Kopcsóné Németh I; Banai J; Ludwig E; Prinz G; Reményi P; Strbák B; Zsoldiné Urbán E; Baji P; Péntek M; Brodszky V
    Orv Hetil; 2013 Jul; 154(30):1188-93. PubMed ID: 23876616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
    Nelson RL; Suda KJ; Evans CT
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
    Musgrave CR; Bookstaver PB; Sutton SS; Miller AD
    Int J Infect Dis; 2011 Jul; 15(7):e438-48. PubMed ID: 21596604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
    Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
    J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.
    Burton HE; Mitchell SA; Watt M
    Pharmacoeconomics; 2017 Nov; 35(11):1123-1140. PubMed ID: 28875314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
    Cornely OA; Miller MA; Louie TJ; Crook DW; Gorbach SL
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S154-61. PubMed ID: 22752865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J; Wattad M; Paul M
    Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract]   [Full Text] [Related]  

  • 37. Fidaxomicin: a new option for the treatment of Clostridium difficile infection.
    Johnson AP; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2788-92. PubMed ID: 22865382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of recurrent Clostridium difficile infection: a systematic review.
    O'Horo JC; Jindai K; Kunzer B; Safdar N
    Infection; 2014 Feb; 42(1):43-59. PubMed ID: 23839210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Rise and Fall of Metronidazole for Clostridium difficile Infection.
    Chahine EB
    Ann Pharmacother; 2018 Jun; 52(6):600-602. PubMed ID: 29424238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
    Bouza E; Muñoz P; Alonso R
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.